Skip to main content

LIVE

INMD

InMode Ltd.

INMD

NASDAQ·Healthcare·Medical - Devices·Mkt cap $857.0M

$14.91

+0.47%

P/E

23.90

Mkt Cap

$857.0M

52-Wk Range

$12.72–$16.74

52-Week Range

$12.72 - $16.74

P/E

23.90

Fwd P/E

11.50

Beta

1.86

Div Yield

0.00%

Avg Vol

712.0K

Shares Out

63.4M

Mkt Cap

$857.0M

Price action

Price chart

Down 2.4% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Proprietary radiofrequency technology platform providing differentiation
  • Comprehensive product portfolio addressing multiple aesthetic procedures
  • Strong intellectual property and patent protection
  • Established global distribution network and brand recognition

Bear Case

1 risk

  • Above-average volatility (beta 1.9).

Growth

Strong growth ahead

Expanding aesthetic medicine market globally with aging demographics

Value

Undervalued - trading well below Medical Devices peers

Momentum

Strong

+10.4% over 3m

Quality

Excellent

Excellent business quality

Dividend

None

No dividend

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Oct 28, 2026

Q3 26 RECAP

AUG 5, 2026

Reported EPS of $0.35 vs $0.35 consensus (+1.2% surprise). Revenue of $95.4M vs $94.9M expected (+0.6%). Beat on both top and bottom lines.

EPS beat +1.2%
Rev beat +0.6%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+1.2%

Revenue trend · last 8Q

-3%

+11%

-28%

+6%

+5%

-0%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$45.3M

$34.0M

$27.1M

$33.2M

$32.4M

$36.1M

$28.5M

$95.6M

Margins · last 8Q

Gross

74.8%

Operating

12.8%

Profit

17.9%

Wall Street consensus

2 analysts · 50% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

50%

Hold

1

50%

Sell

0%

Median Price Target

Latest: Baird · May 7, 2026

vs Industry

How INMD stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.